Signaling is fundamental to how cells sense and respond to their environment—but in immune cells, those signals must be ...
Data are beginning to provide a clearer picture of chimeric antigen receptor T-cell therapy’s benefits and risks in lupus, ...
To turbocharge disease-specific immune responses in patients, CAR-T cells are produced by removing a person's immune T cells and inserting genes that reprogram them to act as guided missiles to ...
Aging does not arrive all at once. It builds quietly across years, touching cells long before symptoms appear.
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present new data at the American ...
A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes ...
SMART control of CAR T cells is advancing cancer immunotherapy by improving precision, safety, and adaptability. Why Smart ...
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500 ...
The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results